1. 5-Amino-1MQ 10mg
2. 5-Amino-1MQ 50mg
3. ACE-031 1mg
4. ACTH 1-39 5mg
5. Adamax 5mg
6. AHK-Cu 50mg
7. AICAR 50mg
8. AICAR 100mg
9. AOD-9604 5mg
10. AOD-9604 10mg
11. Alprostadil 20mcg
12. Amylin 5mg
13. Angiotensin (1–7) 5mg
14. ARA-290 10mg
15. Bimagrumab 5mg
16. Botulinum Toxin 100IU
17. BPC-157 10mg
18. BPC-157 20mg
19. BPC-157 5mg + TB-500 5mg
20. BPC-157 10mg + TB-500 10mg
21. Bronchogen 20mg
22. Cagrilintide 10mg
23. Cagrilintide 20mg
24. Cardiogen 20mg
25. Cartalax 20mg
26. CBL-514 10mg
27. CBL-514 20mg
28. CBL-514 30mg
29. Cerebrolysin 60mg
30. Cerlankin 2mg
31. CGRP (Calcitonin Gene-Related Peptide) 1mg
32. CJC-1295 with DAC 5mg
33. CJC-1295 with DAC 10mg
34. CJC-1295 with DAC 5mg + Ipamorelin 5mg
35. CJC-1295 without DAC 5mg
36. CJC-1295 without DAC 10mg
37. CJC-1295 without DAC 5mg + Ipamorelin 5mg
38. Chonluten 20mg
39. Cortagen 20mg
40. Crystagen 20mg
41. CT-1 Cardiotrophin-1 5mg
42. Dermorphin 5mg
43. Dihexa 5mg
44. DSIP 5mg
45. Dulaglutide 5mg
46. Elabela Apelin 5mg
47. Enfuvirtide 90mg
48. Epithalon 5mg
49. Epithalon 40mg
50. Epithalon 50mg
51. EPO 3000IU
52. FGF21 10mg
53. Follistatin-344 1mg
54. FOXO4 10mg
55. GHK-Cu 50mg
56. GHK-Cu 100mg
57. Ghrelin 10mg
58. GHRP-2 5mg
59. GHRP-6 5mg
60. Glucagon 1mg
61. Glutathione 1500mg
62. Gonadorelin Acetate 2mg
63. Goserelin 10mg
64. GLOW BPC-157 10mg + GHK-Cu 50mg + TB-500 10mg
65. HGH 191AA 15IU
66. HGH 191AA 36IU
67. HGH Fragment 176-191 10mg
68. HGH Fragment 176-191 15mg
69. HMG (Human Menopausal Gonadotropin) 75IU
70. Humanin 10mg
71. Hyaluronic Acid 5mg
72. Hexarelin Acetate 2mg
73. Hexarelin Acetate 5mg
74. IGF-1 LR3 1mg
75. Ipamorelin 5mg
76. Ipamorelin 10mg
77. Kisspeptin-10 5mg
78. Kisspeptin-10 10mg
79. KLOW BPC-157 10mg + GHK-Cu 50mg + TB-500 10mg + KPV 10mg
80. KPV 10mg
81. Leuprolide Acetate 10mg
82. Liraglutide 5mg
83. Livagen 20mg
84. LL-37 5mg
85. Lysyl Oxidase 30mg
86. Matrixyl 10mg
87. Mazdutide 10mg
88. Melanotan I 10mg
89. Melanotan II 10mg
90. Melatonin 10mg
91. MGF 2mg
92. MOTS-c 10mg
93. MOTS-c 40mg
94. NAD+ 100mg
95. NAD+ 500mg
96. NAD+ 1000mg
97. Nesiritide 5mg
98. Neuropeptide Y (NPY) 10mg
99. Ovagen 20mg
100. Oxytocin Acetate 5mg
101. Oxytocin Acetate 10mg
102. P21 5mg
103. P21 10mg
104. PACAP 5mg
105. Pancragen 20mg
106. PE 22-28 10mg
107. PEG-MGF 2mg
108. Pinealon 5mg
109. Pinealon 10mg
110. Pinealon 20mg
111. PNC-27 5mg
112. PNC-27 10mg
113. Prostamax 20mg
114. PT-141 10mg
115. PTH Fragments 10mg
116. Relamorelin 5mg
117. Retatrutide 10mg
118. Retatrutide 20mg
119. Retatrutide 30mg
120. Retatrutide 40mg
121. Retatrutide 60mg
122. Retatrutide 5mg + Cagrilintide 5mg
123. Selank 5mg
124. Selank 10mg
125. Semaglutide 5mg + Cagrilintide 5mg
126. Semax 5mg
127. Sermorelin 5mg
128. SLU-PP-332 10mg
129. SNAP-8 10mg
130. SS-31 10mg
131. SS-31 50mg
132. Survodutide 10mg
133. TB-500 10mg
134. TB-500 (FRAG) 10mg
135. Teduglutide 5mg
136. Teriparatide 10mg
137. Tesamorelin 5mg
138. Tesamorelin 10mg
139. Tesamorelin 20mg
140. Tesamorelin 5mg + Ipamorelin 5mg
141. Tesofensine 1mg
142. Testagen 20mg
143. Thymalin 10mg
144. Thymosin Alpha-1 5mg
145. Thymosin Alpha-1 10mg
146. Treprostinil 5mg
147. Vesugen 20mg
148. VIP 5mg
149. VIP 10mg
150. Vilon 20mg
Retatrutide is a synthetic peptide currently in clinical development, classified as a triple agonist of the GLP‑1, GIP, and glucagon receptors. It was designed to simultaneously modulate multiple metabolic pathways involved in glycemic control, energy balance, and body weight regulation.
R$875,00
143 in stock
Retatrutide is a long‑chain peptide structurally optimized to exhibit high affinity and functional activity at the GLP‑1 (glucagon‑like peptide‑1), GIP (glucose‑dependent insulinotropic polypeptide), and glucagon receptors. This triple mechanism promotes:
The molecule has been chemically modified to extend its plasma half‑life, incorporating non‑natural amino acid substitutions and stabilization strategies against proteolytic degradation, enabling subcutaneous administration at prolonged intervals. Retatrutide is currently in advanced clinical studies, primarily targeting obesity and metabolic disorders.
| Property | Value |
| Molecular Formula | ≈ C₂₆₀H₃₉₅N₅₃O₇₉ (estimated) |
| Molecular Weight | ≈ 5,500 g/mol |
| Synonyms | Retatrutide, LY3437943 (development code), Triple GLP‑1/GIP/Glucagon Agonist |
Main Structure of the Retatrutide Peptide
Source: científico
The peptides undergo a lyophilization process, a technique that contributes to greater stability and durability, while preserving purity and molecular structure during storage. It is important to note that no bulking agents are used during this procedure.
Biopelabs advises: this material is provided exclusively as a chemical input for research purposes. Its use is restricted to in vitro assays and experimental activities in laboratory settings. The information presented is strictly for informational and educational purposes. Handling must be carried out only by properly qualified professionals. This product is not classified as a medication, food, or cosmetic, and must not be used, marketed, or described as such.
Retatrutide is a next-generation peptide that has attracted significant interest in pharmaceutical research due to its multi-target action in energy metabolism. Preclinical studies indicate that this compound has relevant investigational potential in areas such as obesity, type 2 diabetes, and complex metabolic disorders. Although clinical data in humans are still under development, early results from experimental models position Retatrutide as an important subject of study in modern pharmacology.
The primary distinguishing feature of Retatrutide lies in its ability to simultaneously activate three key hormonal receptors involved in metabolic regulation:
GLP-1, GIP, and glucagon.
This integrated activation has been widely studied for enabling a more comprehensive physiological response, acting across different metabolic pathways. Experimental research investigates how this approach may:
This combination of effects makes Retatrutide a strategic compound for research focused on multifactorial metabolic conditions, such as metabolic syndrome.
Preclinical studies have explored the potential of Retatrutide in preventing diet-induced weight gain and reducing insulin resistance. Data suggest that its integrated mechanism of action may result in more consistent metabolic effects compared to single-target agonists.
In the context of type 2 diabetes research, Retatrutide is being investigated for its ability to modulate glucose homeostasis, influencing both hepatic glucose production and peripheral glucose uptake.
These combined effects make the peptide a promising target in studies focused on energy balance and systemic metabolism.
The reliability of results in pharmaceutical research is directly dependent on the quality and consistency of the compounds used. Biopelabs provides Retatrutide exclusively for research purposes, with strict control over synthesis, purification, and analysis.
The use of peptides with a high degree of analytical purity contributes to:
These factors are essential for the safe and consistent advancement of scientific research.
Retatrutide represents a growing trend in pharmacology: the development of molecules capable of acting simultaneously on multiple physiological pathways. This approach reflects a paradigm shift in the research of metabolic treatments, aiming for more integrated and effective solutions.
Access to high-quality peptides, such as those provided by Biopelabs, is a key element in enabling studies that investigate the true potential of these new therapeutic strategies.
Scientific research involving Retatrutide (CAS 2381089-83-2) plays a relevant role in the current landscape of pharmaceutical investigation. Its multi-receptor mechanism and widely studied metabolic effects make it a compound of significant experimental interest.
Biopelabs remains committed to supporting scientific research by supplying peptides intended exclusively for experimental studies, contributing to the advancement of knowledge and the development of next-generation therapies.
The Role of the Retatrutide Peptide in Next-Generation Pharmaceutical Research
https://www.nbinno.com/pt/article/intermediarios-farmaceuticos/papel-retatrutide-peptideo-pesquisa-farmaceutica-nova-geracao
Retatrutide Peptide at Scale: Cost-Effective Supply for Your Laboratory
https://www.nbinno.com/pt/article/intermediarios-farmaceuticos/retatrutide-peptideo-larga-escala-fornecimento-economico-laboratorio
Only logged in customers who have purchased this product may leave a review.
| Weight | 40 g |
|---|---|
| Dimensions | 7 × 3,6 × 8 cm |
Reviews
There are no reviews yet.